Introduction to Deep Brain Stimulation (DBS)
- DBS is a neurosurgical intervention targeting pathological neural circuits.
- Involves implantation of electrodes in specific brain regions with electrical stimulation from an implanted battery.
- Over 160,000 patients have undergone DBS globally for various conditions.
Advantages of DBS
- Non-lesional approach avoids permanent damage to brain tissue.
- Stimulation parameters can be adjusted to maximize therapeutic benefit and minimize side effects.
- Provides direct access to pathological circuits driving symptoms.
- Enables investigation of physiological dysfunction and informs both therapy and technology development.
- Focal intervention (millimetre precision) demonstrates localized dysfunction affecting global networks.
Dual Role of DBS
- Acts as both a modulator and investigative probe of brain circuits.
- Expands applications beyond motor symptoms to limbic, cognitive, and memory disorders.
Limitations and Risks
- DBS is an invasive procedure with risks like haemorrhage and infection.
- Outside of movement disorders, use is restricted to treatment-refractory cases in specialized centers.
Current Clinical Indications
- Majority of DBS procedures are for movement disorders, especially Parkinson’s disease (PD).
- RCTs confirm DBS as highly effective for motor symptoms in PD.
Challenges in Parkinson’s Disease
- Common targets: Subthalamic nucleus (STN) and Globus pallidus internus (GPi).
- DBS often ineffective for axial symptoms (e.g., gait), and may worsen speech or cognitive symptoms.
- Highlights the limitation of focal interventions for multisystem circuit disorders.
Technical and Clinical Challenges
- Need for technical innovations:
- Longer battery life.
- Smaller device designs.
- Adaptive stimulation systems.
- Wireless technology integration.
Future Directions
- Expand DBS to other circuitopathies (e.g., depression, Alzheimer’s disease).
- Address global ageing populations.
Conclusion
- Broader application depends on understanding brain circuit dysfunction.
- Need for preclinical models to inform translation.
- Expansion of indications beyond motor disorders.
- Addressing ethical, technical, and clinical concerns will shape the field.
Rationale and Mechanisms of Action of DBS
Overview
- DBS is transforming the management and conceptualization of brain disorders.
- It bridges clinical therapy and scientific exploration of brain circuitry.
- Ongoing research aims to refine DBS for broader, safer, and more effective use.
Ionic and Cellular Mechanisms
- Multiple hypotheses proposed to explain DBS mechanisms.
- Most prevailing theory: stimulation-induced disruption of pathological circuit activity.
- Effects occur at multiple levels — ionic, cellular, and network — to improve symptoms.
- High-frequency (~100 Hz) stimulation produces different outcomes than low-frequency (~10 Hz) stimulation.
Information Lesion Hypothesis
- Electrode as cathode redistributes Na+ and Cl− ions in extracellular space.
- Electric field manipulates voltage sensors on sodium channel proteins, initiating action potentials.
- Action potentials propagate both orthodromically and antidromically across axons.
- Axons can follow 100 Hz stimulation; synapses cannot sustain transmission as effectively.
- High-frequency activity may exhaust neurotransmitter pools and desensitize receptors.
- Leads to synaptic filtering: suppression of low-frequency signal transmission.
Contradictory Evidence and Network-Level Insights
- High-frequency stimulation creates an "information lesion": signal has no information content.
- DBS-induced action potentials override intrinsic neuronal activity.
- Disruption of low-frequency oscillations prevents pathological signal propagation.
- Information lesion and synaptic filtering may act synergistically.
Role of Thalamus and Circuit Resonance
- Some studies in awake primates show preserved sensorimotor-related discharge during STN/GPi DBS.
- Implies DBS may act more as a selective filter than as a total signal block.
- Other basal ganglia functions (e.g., learning, decision-making) often remain intact during DBS.
- Basal ganglia networks may support physiological coding via mechanisms not reliant on synchronization.
Generic Application of DBS
- Thalamus may act as a low-pass filter: passes low-frequency signals (<30 Hz), blocks high-frequency (>100 Hz).
- Circuit resonance changes in PD may promote entrainment by low-frequency signals.
- DBS may effectively suppress low-frequency oscillations with minimal impact on overall network function.
Long-Term and Delayed Effects
- High-frequency DBS can override various low-frequency pathological rhythms.
- Applicable to conditions like tremor, dystonia, and akinetic-rigid syndromes.
Emerging Mechanisms: Role of Astrocytes
- Acute effects do not explain delayed benefits seen in dystonia, depression, and epilepsy.
- Chronic DBS may induce adaptive neuroplastic changes.
- Hypothesis: Low-frequency oscillations promote maladaptive plasticity (LTP), which DBS may disrupt.
- DBS may upregulate trophic and synaptic proteins over time, enhancing plasticity.
Insights from Animal Models in DBS
General Role of Animal Models
- Astrocytes play a critical role in synaptic integration and plasticity regulation.
- DBS may influence astrocytic function, contributing to delayed clinical improvements.
Parkinson’s Disease (PD) and the STN Model
- Animal studies have been critical in translating DBS from concept to clinical use.
- They provide mechanistic understanding and help identify potential DBS targets.
Epilepsy and the Mammillothalamic Tract (MMT)
- MPTP-induced parkinsonism in non-human primates revealed hyperactivity in the subthalamic nucleus (STN).
- Lesions of the STN alleviated motor symptoms (rigidity, hypokinesia), eliminating the need for levodopa or apomorphine.
- Led to the concept of using high-frequency DBS as a functional alternative to lesioning.
- High-frequency STN stimulation in MPTP-treated monkeys improved motor disability — directly supporting clinical use in PD.
Depression and Affective Disorders
- In guinea pigs, lesioning the MMT increased seizure threshold — implicating its role in seizure propagation.
- MMT and its major projection site, the anterior nucleus of the thalamus (ANT), were shown to have anti-epileptic potential.
- Electrical stimulation of MMT or ANT in animals reduced seizures, leading to clinical trials of ANT DBS in epilepsy.
Tourette Syndrome
- Rodent models (chronic mild stress) used to evaluate DBS targets for depression.
- Different brain regions influence different aspects of mood-related behaviors:
- Nucleus accumbens / lateral habenula: Improve motivation, reduce anxiety.
- Ventromedial prefrontal cortex: Enhance hedonia and reduce despair.
Mechanistic Insights from Animal Studies
- Stimulation of the anteromedial STN in monkeys with tic-like behaviors reduced stereotyped movements.
- Supports region-specific modulation of behaviors in neuropsychiatric syndromes.
Login to Read More
